Literature DB >> 28288283

3D Models of the NCI60 Cell Lines for Screening Oncology Compounds.

Mike Selby1, Rene Delosh1, Julie Laudeman1, Chad Ogle1, Russell Reinhart1, Thomas Silvers1, Scott Lawrence1, Robert Kinders1, Ralph Parchment1, Beverly A Teicher2, David M Evans1.   

Abstract

The NCI60 cell line panel screen includes 60 human tumor cell lines derived from nine tumor types that has been used over the past 20+ years to screen small molecules, biologics, and natural products for activity. Cells in monolayer culture in 96-well plates are exposed to compounds for 48 h, and Sulforhodamine B is used to determine cell viability. Data analysis tools such as COMPARE allow classification of compounds based on the pattern of cell line response. However, many compounds highly active in monolayer cell culture fail to show efficacy in vivo. Therefore, we explored 3D culture of the NCI60 panel as a strategy to improve the predictive accuracy of the screen. 3D cultures more closely resemble tumors than monolayer cultures with tighter cell-cell contact and nutrient and oxygen gradients between the periphery and the center. We optimized the NCI60 cell line panel for generating 3D spheroids of a prespecified diameter (300-500 µm) in ultra-low attachment (ULA) plates. Spheroids were classified into four categories based on imaging, and concentration response of select agents in 2D and 3D models is presented.

Entities:  

Keywords:  3D; NCI60 cells; ULA plates; cell culture; spheroids

Mesh:

Substances:

Year:  2017        PMID: 28288283     DOI: 10.1177/2472555217697434

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  17 in total

1.  Exposure time versus cytotoxicity for anticancer agents.

Authors:  David M Evans; Jianwen Fang; Thomas Silvers; Rene Delosh; Julie Laudeman; Chad Ogle; Russell Reinhart; Michael Selby; Lori Bowles; John Connelly; Erik Harris; Julia Krushkal; Larry Rubinstein; James H Doroshow; Beverly A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  2019-05-17       Impact factor: 3.333

2.  Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.

Authors:  Shilpaa Mukundan; Jordan Bell; Matthew Teryek; Charles Hernandez; Andrea C Love; Biju Parekkadan; Leo Li-Ying Chan
Journal:  J Fluoresc       Date:  2022-01-06       Impact factor: 2.217

3.  Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio.

Authors:  Jeffrey C Buchsbaum; Michael G Espey; Ceferino Obcemea; Jacek Capala; Mansoor Ahmed; Pataje G Prasanna; Bhadrasain Vikram; Julie A Hong; Beverly Teicher; Molykutty J Aryankalayil; Michelle A Bylicky; C Norman Coleman
Journal:  J Clin Oncol       Date:  2022-03-04       Impact factor: 50.717

4.  Establishment and characterization of NCC-LMS2-C1-a novel patient-derived cancer cell line of leiomyosarcoma.

Authors:  Rei Noguchi; Yuki Yoshimatsu; Takuya Ono; Akane Sei; Kaoru Hirabayashi; Iwao Ozawa; Kazutaka Kikuta; Tadashi Kondo
Journal:  Hum Cell       Date:  2020-10-01       Impact factor: 4.174

5.  Smart Material Hydrogel Transfer Devices Fabricated with Stimuli-Responsive Silk-Elastin-Like Proteins.

Authors:  Rachael N Parker; Dana M Cairns; Wenyao A Wu; Kathryn Jordan; Chengchen Guo; Wenwen Huang; Zaira Martin-Moldes; David L Kaplan
Journal:  Adv Healthc Mater       Date:  2020-04-27       Impact factor: 9.933

6.  High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.

Authors:  Stanton J Kochanek; David A Close; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2018-12-28       Impact factor: 1.738

7.  Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines.

Authors:  Stanton J Kochanek; David A Close; Daniel P Camarco; Paul A Johnston
Journal:  SLAS Discov       Date:  2020-01-25       Impact factor: 3.341

8.  Synergistic combination of PMBA and 5-fluorouracil (5-FU) in targeting mutant KRAS in 2D and 3D colorectal cancer cells.

Authors:  Arem Qayum; Asmita Magotra; Syed Mohmad Shah; Utpal Nandi; P R Sharma; Bhahwal Ali Shah; Shashank Kumar Singh
Journal:  Heliyon       Date:  2022-03-16

9.  Comparative Analysis of 3D Bladder Tumor Spheroids Obtained by Forced Floating and Hanging Drop Methods for Drug Screening.

Authors:  Robson L F Amaral; Mariza Miranda; Priscyla D Marcato; Kamilla Swiech
Journal:  Front Physiol       Date:  2017-08-22       Impact factor: 4.566

Review 10.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.